Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Aptose Biosciences, Inc. (APTOF) had Weighted-Average Shares Outstanding (Diluted) of 2.55M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-5.12M |
|
-- |
|
-- |
|
$4.91M |
|
$-4.91M |
|
$-0.21M |
|
$-5.12M |
|
$-5.12M |
|
$-5.12M |
|
$-5.12M |
|
$-5.12M |
|
$-5.12M |
|
$-4.91M |
|
$-4.80M |
|
2.55M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
2.55M |
$-2.01 |
|
$-2.01 |
|
| Balance Sheet Financials | |
$3.78M |
|
$0.01M |
|
$2.56M |
|
$6.34M |
|
$7.08M |
|
$18.71M |
|
$18.71M |
|
$25.79M |
|
$-19.45M |
|
$-19.45M |
|
$-19.45M |
|
2.55M |
|
| Cash Flow Statement Financials | |
$-16.15M |
|
-- |
|
$11.08M |
|
$6.71M |
|
$1.64M |
|
$-5.07M |
|
$0.43M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.53 |
|
-- |
|
-- |
|
-25.36 |
|
-0.96 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-16.15M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
26.34% |
|
26.34% |
|
-80.79% |
|
694.17% |
|
$-7.62 |
|
$-6.33 |
|
$-6.33 |
|